Koyfin Home > Directory > Health Care > Albireo Pharma Inc > Long-Term Debt

Albireo Pharma Inc Long-Term Debt Chart (ALBO)

Albireo Pharma Inc annual/quarterly Long-Term Debt from 2015 to 2020.
  • Albireo Pharma Inc Long-Term Debt for the quarter ending June 06, 2020 was $9m a 48.23% increase of 5m year over year
  • Albireo Pharma Inc Long-Term Debt for the last 12 months ending June 06, 2020 was $9m a 48.23% increase of 5m year over year
  • Albireo Pharma Inc Annual Long-Term Debt for 2015 was $5m a -6.31% decrease of 0m from 2014
  • Albireo Pharma Inc Annual Long-Term Debt for 2014 was $5m
Other Cash Flow Metrics:
  • Albireo Pharma Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $-10m a 110.98% decrease of -11m year over year
  • Albireo Pharma Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-10m a 91.45% decrease of -10m year over year
  • Albireo Pharma Inc Total Revenue for the quarter ending September 09, 2018 was $0m a 100.42% increase of 0m year over year
View Chart On Koyfin

Quarterly ALBO Long-Term Debt Data

06/2020$9m
09/2016$4m
06/2016$5m
12/2015$5m

Annual ALBO Long-Term Debt Data

2015$5m
2014$5m